[Treatment of primary disease (breast, non-small cell lung and prostate cancers) with irradiation in case of de novo metastatic cancer]
- PMID: 31501025
- DOI: 10.1016/j.canrad.2019.08.004
[Treatment of primary disease (breast, non-small cell lung and prostate cancers) with irradiation in case of de novo metastatic cancer]
Abstract
The basis of treatment of primary disease in case of metastatic cancer at diagnosis is based on the knowledge of the natural history of the disease, the biology of the primary tumour and its metastases, advances in modern radiotherapy techniques (modulated intensity, stereotactic radiotherapy) in order to improve the survival of patients with advanced disease. The clinical concept of oligometastatic disease at diagnosis has repositioned the interest of local treatment for primitive disease because these patients have a slower evolutionary profile than metastatic disease extended from the outset. This article reviews the indication of radiotherapy as a local treatment for primary cancer in a de novo metastatic diagnosed disease in the case of breast cancer, non-small cell lung cancer and prostate cancer.
Keywords: Breast; Cancer métastatique; Clinical trials; Essais cliniques; Lung; Metastatic cancer; Poumon; Primary tumour; Prostate; Radiotherapy; Radiothérapie; SBRT; Sein; Stéréotaxie; Tumeur primitive.
Copyright © 2019 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
Similar articles
-
[Treatment of primary disease with irradiation in case of de novo metastatic breast cancer].Cancer Radiother. 2020 Oct;24(6-7):567-575. doi: 10.1016/j.canrad.2020.06.008. Epub 2020 Aug 16. Cancer Radiother. 2020. PMID: 32814669 Review. French.
-
[Treatment of oligometastatic or oligoprogression cancer].Cancer Radiother. 2019 Oct;23(6-7):482-485. doi: 10.1016/j.canrad.2019.07.143. Epub 2019 Sep 5. Cancer Radiother. 2019. PMID: 31495737 Review. French.
-
Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort.Radiother Oncol. 2024 Oct;199:110466. doi: 10.1016/j.radonc.2024.110466. Epub 2024 Jul 31. Radiother Oncol. 2024. PMID: 39094630
-
Radiotherapy for primary tumor in lung cancer with synchronous metastases: Overview from the past and proposal for the future.Cancer Radiother. 2020 Oct;24(6-7):554-558. doi: 10.1016/j.canrad.2020.06.014. Epub 2020 Aug 20. Cancer Radiother. 2020. PMID: 32828666 Review.
-
Recent advances in de-intensification of radiotherapy in elderly cancer patients.F1000Res. 2020 May 27;9:F1000 Faculty Rev-447. doi: 10.12688/f1000research.21151.1. eCollection 2020. F1000Res. 2020. PMID: 32518630 Free PMC article. Review.
Cited by
-
Analysis of Clinical Characteristics, Treatment, and Prognostic Factors of 106 Breast Cancer Patients With Solitary Pulmonary Nodules.Front Surg. 2022 Feb 15;9:843913. doi: 10.3389/fsurg.2022.843913. eCollection 2022. Front Surg. 2022. PMID: 35242809 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical